Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump ...

Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...